Cristiane M. Ida

ORCID: 0000-0003-2768-2913
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Glioma Diagnosis and Treatment
  • Cancer, Hypoxia, and Metabolism
  • Cancer Genomics and Diagnostics
  • Radiomics and Machine Learning in Medical Imaging
  • Sarcoma Diagnosis and Treatment
  • Ocular Oncology and Treatments
  • MicroRNA in disease regulation
  • Neurofibromatosis and Schwannoma Cases
  • Prostate Cancer Treatment and Research
  • Brain Metastases and Treatment
  • Neuroblastoma Research and Treatments
  • Meningioma and schwannoma management
  • Epigenetics and DNA Methylation
  • Histiocytic Disorders and Treatments
  • Cancer-related molecular mechanisms research
  • Chromatin Remodeling and Cancer
  • Hereditary Neurological Disorders
  • Vascular Tumors and Angiosarcomas
  • Histone Deacetylase Inhibitors Research
  • Genomics and Rare Diseases
  • Lung Cancer Treatments and Mutations
  • Peripheral Nerve Disorders
  • BRCA gene mutations in cancer
  • Genetic Neurodegenerative Diseases
  • Ferroptosis and cancer prognosis

Mayo Clinic
2014-2025

Mayo Clinic in Arizona
2013-2025

Mayo Clinic in Florida
2019-2023

University of Minnesota Rochester
2015-2022

Dell Children's Medical Center of Central Texas
2019

University of North Carolina at Chapel Hill
2018

University of Washington
2015

Salmaniya Medical Complex
2015

WinnMed
2013

Universidade de São Paulo
2009

Abstract Prognostic significance of histological anaplasia and BRAF V600E mutation were retrospectively evaluated in 74 patients with pleomorphic xanthoastrocytoma ( PXA ). Median age at diagnosis was 21.5 years (31 pediatric, 43 adult) median follow‐up 7.6 years. Anaplasia ‐ AF ), defined as mitotic index ≥ 5/ 10HPF and/or presence necrosis, present 33 cases. detected 39 (of 60) cases by immunohistochemical molecular analysis, all negative for IDH1 R132H Mitotic necrosis associated...

10.1111/bpa.12217 article EN Brain Pathology 2014-10-16
Christopher S. Chen Edward Franklin Y Li Nelly Joseph‐Mathurin Anthony S. Burns and 95 more G Wang Tammie L.S. Benzinger Randall J. Bateman Richard J. Perrin Sonal Agrawal Lei Yu Lisa L. Barnes David A. Bennett Julie A. Schneider Martha Clare Morris Genevieve Stein-O’Brien Ryan G. Palaganas Elaine C. Meyer Javier Redding‐Ochoa Olga Pletnikova H Guo William R. Bell Juan C. Troncoso Richard L. Huganir Adam Seth Levine Julie Bennett Chantel Cacciotti Samantha J DeMarsh Adriana Rodrigues Fonseca Guerreiro Stuecklin Jordan R. Hansford Louise E. Ludlow M. Aaron MacNeil Jean M. Mulcahy Levy Parag G. Patil Ashley Plant Beverley Wilson Fleming Richard Graham Joseline Haizel‐Cobbina Yoshiko Nakano Salmo Raskin Christopher Dunham Craig Erker C Li Mona Nasrallah E. C. Nelson Mohit Rana M Santi-Vicini Frank van Landeghem J Vel Azquez Vega Richard Yuditskiy Michael C. Dewan Uri Tabori Cynthia Hawkins Kenneth Aldape D. Hoang Elizabeth P. Shulman Emma M. Campagnolo Zied Abdullaev H Lalchungnunga Om V. Singh Eric A. Stone Eytan Ruppin Y. Zhu Darin D. Carabenciov D Johnson Jorge Trejo‐Lopez Andrew Nguyen A Raghunathan G Lanzino Cristiane M. Ida Zepeda Mendoza Giannini Mayo Professor Nikhil Patel Lynn M. Bekris Shane Formica Debby W. Tsuang Cyrus P. Zabetian Irene Litvan Jori Fleisher Sarah Berman David J. Irwin Andrea Bozoki Carol F. Lippa F. DiFillipo Lorna M. Lopez Douglas Galasko James B. Leverenz Marvin J. Miller C.M. Ma G Dong Suresh R. Naik Gannon A. McDonough Shaokuan Mao Ann C. McKee Annie Huang Anna F. Lee Yoshiaki MATSUMOTO D Silverbush

Background: Clinical trials of anti-Aβ monoclonal antibodies in Alzheimer disease (AD) infer target engagement from Aβ positron emission tomography (PET) and/or fluid biomarkers such as cerebrospinal (CSF) Aβ42/40.However, these measure deposits indirectly incompletely.In contrast, postmortem neuropathologic assessments allow direct investigation treatment effects on brain and many other pathologic features.Methods: From a clinical trial dominantly inherited AD, we measured...

10.1093/jnen/nlae036 article EN other-oa Journal of Neuropathology & Experimental Neurology 2024-05-10

Abstract Diffuse midline glioma, H3 K27-altered (DMG-H3 K27) is an aggressive group of diffuse gliomas that predominantly occurs in pediatric patients, involves structures, and displays loss p.K28me3 (K27me3) expression by immunohistochemistry characteristic genetic/epigenetic profile. Rare examples a glioma with p.K28M (K27M) mutation without involvement the so-called “diffuse hemispheric mutation” (DHG-H3 K27), have been reported. Herein, we describe 2 additional cases radiologically...

10.1093/jnen/nlae018 article EN cc-by-nc Journal of Neuropathology & Experimental Neurology 2024-03-06

Abstract Background Glioblastoma (GBM) represents an aggressive cancer type with a median survival of only 14 months. With fewer than 5% patients surviving 5 years, comprehensive profiling these rare could elucidate prognostic biomarkers that may confer better patient outcomes. We utilized multiple molecular approaches to characterize the largest cohort isocitrate dehydrogenase (IDH)–wildtype GBM long-term survivors (LTS) date. Methods Retrospective analysis was performed on 49 archived...

10.1093/neuonc/noz129 article EN Neuro-Oncology 2019-07-24

High frequencies of the BRAF V600E mutation have been reported in pleomorphic xanthoastrocytoma (PXA). Recently, a mutation-specific antibody has developed and validated. We evaluated immunohistochemical (IHC) detection PXA by comparing to gold standard molecular analysis investigating interobserver variability IHC scoring. performed 46 cases, which 37 (80%) cases had sufficient tumor tissue for analysis. was using monoclonal mouse VE1 (Spring Bioscience). slides were scored independently...

10.1186/2051-5960-1-20 article EN cc-by Acta Neuropathologica Communications 2013-05-30

Primary high-grade infiltrating gliomas of the spinal cord are rare, with prior series including limited numbers cases and reporting poor outcomes. Additionally, molecular profile has not been well characterized. We identified 13 adult patients whose surgery had performed at our institution over a 26-year-period. Radiologically, nine harbored regions post-contrast enhancement. Existing slides were reviewed, when sufficient tissue was available, immunohistochemical stains (IDH1-R132H,...

10.1038/s41379-019-0271-3 article EN publisher-specific-oa Modern Pathology 2019-04-26

Abstract PURPOSE: Monitoring disease progression in patients with high-grade gliomas (HGGs) is challenging due to treatment-related changes on imaging and the requirement for neurosurgical intervention obtain diagnostic tissue. DNA junctions HGGs often amplify oncogenes, making these fragments potentially more abundant blood than monoallelic mutations. Herein, we piloted a cell-free approach detection plasma of by leveraging patient-specific associated oncogene amplifications. EXPERIMENTAL...

10.1158/1078-0432.ccr-24-3233 article EN cc-by-nc-nd Clinical Cancer Research 2025-02-28

Journal Article Expanding the spectrum of TERT promoter mutations in CNS tumors: A case series non-canonical Get access David J Cook, MD, MD Department Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States https://orcid.org/0009-0007-6196-4179 Search for other works by this author on: Oxford Academic PubMed Google Scholar Jorge Trejo-Lopez, Beth Pitel, MS, MS Neiladri Saha, Quantitative Health Sciences, Tejaswi Koganti, Jayson Hardcastle, PhD, PhD Stephanie Smoley,...

10.1093/jnen/nlaf022 article EN Journal of Neuropathology & Experimental Neurology 2025-03-07

Abstract The objective of this study was to assess the relationship tumor protein levels TOP2A and MIB-1 ERG status with cancer-specific outcomes in men high-risk prostate cancer treated by radical prostatectomy (RP). A 150-pair case-control designed from RP patients who developed systemic progression (SP) within 6 years (cases) were free disease at least 8 after (controls). cases controls matched on conventional prognostic clinical parameters. assessed immunohistochemical methods,...

10.1158/0008-5472.can-10-1358 article EN Cancer Research 2010-11-10

Primary schwannoma of the bone, defined as arising within medullary cavity and radiologically mimicking more common primary bone tumors, is rare. We present 17 13 conventional schwannomas, 4 melanotic type. Collectively, they represented <1% all tumors seen at Mayo Clinic over a 33-year period. Most affected long bones. There was slight female predilection. Fifteen were sporadic, 2 syndrome associated (Carney complex). Pain most symptom. Given their rarity, schwannomas are not usually...

10.1097/pas.0b013e31821fcc0c article EN The American Journal of Surgical Pathology 2011-06-15

In Brief Gout is a painful inflammatory arthropathy caused by crystallization of monosodium urate within the joints. We present case patient with primary gout who had positive results joint aspiration and synovial biopsy for crystals in third metacarpophalangeal but false-negative dual-energy computed tomography. Although DECT very promising likely to be specific MSU deposition this microscopic crystal proof may have too few detection.

10.1097/rhu.0b013e318253aa5e article EN JCR Journal of Clinical Rheumatology 2012-04-01

Cerebellar low-grade astrocytomas with a diffuse pattern of growth are uncommon, comprising World Health Organization (WHO) grade II (DA) and minority WHO I pilocytic (PA), so-called PA, "diffuse variant." Among 106 cerebellar (WHO II) operated on at the Mayo Clinic (1984–2010), we identified 19 such cases: 8 variant," 5 DA, 6 that were unable to classify further (low-grade astrocytomas, subtype indeterminate). We characterized these tumors using immunohistochemistry currently available...

10.1097/nen.0b013e31825c448a article EN Journal of Neuropathology & Experimental Neurology 2012-06-17

Abstract Background Oligodendroglioma is genetically defined by concomitant IDH (IDH1/IDH2) mutation and whole-arm 1p/19q codeletion. Codeletion of traditionally evaluated fluorescence in situ hybridization (FISH) cannot distinguish partial from Partial codeletion called positive FISH diagnostically a “false-positive” result. Chromosomal microarray (CMA) discriminates Herein, we aimed to estimate the frequency that would lead false-positive Methods test probe coordinates were mapped onto...

10.1093/noajnl/vdaa109 article EN cc-by-nc Neuro-Oncology Advances 2020-01-01

Polymorphous low-grade neuroepithelial tumor of the young (PLNTY) is a recently described epileptogenic characterized by oligodendroglioma-like components, aberrant CD34 expression, and frequent mitogen-activated protein kinase (MAPK) pathway activation. We molecularly profiled 13 cases with diagnostic histopathological features PLNTY (10 female; median age, 16 years; range, 5-52). Patients frequently presented seizures (9 12 available history) temporal lobe tumors 13). MAPK activating...

10.1093/jnen/nlab075 article EN Journal of Neuropathology & Experimental Neurology 2021-08-07

Adipose tissue tumors of the retroperitoneum showing no identifiable cytologic atypia are usually classified as lipomalike well-differentiated liposarcoma. Whether a subset these represents true examples retroperitoneal lipoma remains controversial subject, because diagnostic liposarcoma cells may be difficult identification, even after extensive sampling. Herein, we describe large with classic histopathologic, cytogenetic, molecular and genetic features. Extensive morphologic inspection...

10.1097/pas.0b013e318160cfbf article EN The American Journal of Surgical Pathology 2008-05-22

Hypoxia has been associated with malignant progression, metastasis and resistance to therapy. Hence, we studied expression of hypoxia–regulated genes in 100 prostate cancer (CaP) bulk tissues 71 adjacent benign tissues. We found 24 transcripts significantly overexpressed (p≤0.02). Importantly, higher transcript levels disc large (drosophila) homolog-associated protein 5 (DLGAP5)/discs homolog 7 (DLG7)/hepatoma up-regulated (HURP), hyaluronan-mediated motility receptor (HMMR) cyclin B1...

10.1371/journal.pone.0082833 article EN cc-by PLoS ONE 2013-12-09

Amplification of a CAG trinucleotide motif (CTG18.1) within the TCF4 gene has been strongly associated with Fuchs Endothelial Corneal Dystrophy (FECD). Nevertheless, small minority clinically unaffected elderly patients who have expanded CTG18.1 sequences identified. To test hypothesis that expansions in these are protected from FECD because they interruptions repeats, we utilized combination an amplification-free, long-read sequencing method and new target-enrichment sequence analysis tool...

10.1371/journal.pone.0219446 article EN cc-by PLoS ONE 2019-07-05

Abstract MAPK pathway activation has been recurrently observed in desmoplastic infantile ganglioglioma/astrocytoma (DIG/DIA) with reported disproportionally low mutation allele frequencies relative to the apparent high tumor content, suggesting that alterations may be subclonal. We sought expand number of molecularly profiled cases and investigate if cell composition could account for frequencies. Molecular (targeted neuro-oncology next-generation sequencing/RNA sequencing OncoScan...

10.1093/jnen/nlz086 article EN Journal of Neuropathology & Experimental Neurology 2019-09-28

Posterior fossa (PF) diffuse gliomas in pediatric patients frequently harbor the H3 K27M mutation. Among adults, PF are rare, with limited data regarding molecular features and clinical outcomes. We identified 28 adult glioma (17 males; median: 50 y, range: 19 to 78 y), surgery performed at our institution (13 brainstem; 15 cerebellum). Histologic subtypes included anaplastic astrocytoma (n=21), glioblastoma (n=6), (n=1). Immunohistochemistry was for (n=26), IDH1-R132H (n=28), ATRX (n=28). A...

10.1097/pas.0000000000001690 article EN The American Journal of Surgical Pathology 2021-02-16
Coming Soon ...